awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37222845-062B13B2-69FF-48A6-A76E-4E2A9CF4DC32
Q37222845-062B13B2-69FF-48A6-A76E-4E2A9CF4DC32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37222845-062B13B2-69FF-48A6-A76E-4E2A9CF4DC32
Targeting Hsp90: small-molecule inhibitors and their clinical development.
P2860
Q37222845-062B13B2-69FF-48A6-A76E-4E2A9CF4DC32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37222845-062B13B2-69FF-48A6-A76E-4E2A9CF4DC32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cbe3177c1244c371eb509a144f0ba2601aca8f3e
P2860
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study.